Involvement of non-NMDA glutamate receptors of the hypothalamic paraventricular nucleus in the cardiovascular response to the microinjection of noradrenaline into the dorsal periaqueductal gray area of rats

Brain Res. 2015 Mar 30:1602:96-105. doi: 10.1016/j.brainres.2015.01.023. Epub 2015 Jan 21.

Abstract

The dorsal periaqueductal gray area (dPAG) is involved in cardiovascular modulation. In a previous study, we showed that noradrenaline (NA) microinjected into the dPAG caused a vasopressin-mediated pressor response, involving a relay in the hypothalamic paraventricular nucleus (PVN). In the present study, we evaluated the involvement of ionotropic glutamate receptors within the PVN in the cardiovascular response to NA microinjection into the dPAG of unanesthetized rats. Microinjection of the selective NMDA glutamate receptor antagonist LY235959 (2nmol/100nL) unilaterally into the PVN did not affect the cardiovascular response evoked by microinjection of NA (15nmol/50nL) into the dPAG. On the other hand, unilateral PVN pretreatment with the non-NMDA glutamate receptor antagonist NBQX (2nmol/100nL) significantly reduced the pressor and cardiac response caused by microinjection of NA into the dPAG. In addition, bilateral PVN pretreatment with NBQX (2nmol/100nL) blocked the cardiovascular response to NA injected into the dPAG. In conclusion, the present results suggest that bilateral PVN activation of non-NMDA glutamate receptors mediates the vasopressin-related cardiovascular response to the microinjection of NA into the dPAG.

Keywords: Blood pressure; Non-NMDA glutamate receptors; Noradrenaline; Paraventricular nucleus of hypothalamus; Periaqueductal gray area; Vasopressin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / administration & dosage
  • Animals
  • Blood Pressure / drug effects
  • Blood Pressure / physiology*
  • Bradycardia / metabolism
  • Catheters, Indwelling
  • Excitatory Amino Acid Antagonists / pharmacology
  • Heart Rate / drug effects
  • Heart Rate / physiology*
  • Isoquinolines / pharmacology
  • Male
  • Microinjections
  • Norepinephrine / administration & dosage
  • Norepinephrine / metabolism*
  • Paraventricular Hypothalamic Nucleus / drug effects
  • Paraventricular Hypothalamic Nucleus / metabolism*
  • Periaqueductal Gray / drug effects
  • Periaqueductal Gray / metabolism*
  • Quinoxalines / pharmacology
  • Rats, Wistar
  • Receptors, AMPA / antagonists & inhibitors
  • Receptors, AMPA / metabolism
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / metabolism

Substances

  • Adrenergic alpha-Agonists
  • Excitatory Amino Acid Antagonists
  • Isoquinolines
  • Quinoxalines
  • Receptors, AMPA
  • Receptors, N-Methyl-D-Aspartate
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • LY 235959
  • Norepinephrine